Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phylagen is a biotechnology company specializing in environmental genomics and the analysis of the indoor microbiome. The company leverages advanced DNA sequencing and proprietary data analytics to map microbial signatures in indoor environments, such as offices, warehouses, and factories, to improve public health and safety. Their platform provides actionable insights for pathogen monitoring, including the detection of SARS-CoV-2, and verifies the geographic origin of goods by analyzing unique microbial fingerprints. By digitizing the biological data of the physical world, Phylagen aims to create safer and more transparent global environments for businesses and consumers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phylagen.